nilvadipine
Sign in to saveAlso known as CL-287389, Nivadil, FK-235, SK&F-102362
Nilvadipine is a calcium channel blocker (CCB) used for the treatment of hypertension and chronic major cerebral artery occlusion.
Research
334 papers- Nilvadipine: profile of a new calcium antagonist. An overview.Journal of cardiovascular pharmacology · 1994
- Pharmacokinetics of nilvadipine.Journal of cardiovascular pharmacology · 1992
- Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.Drugs & aging · 1995
- Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.PLoS medicine · 2018
- Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.Journal of cardiovascular pharmacology · 1992
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- Experimental research
- References
Nilvadipine is a calcium channel blocker (CCB) used for the treatment of hypertension and chronic major cerebral artery occlusion.
Pathohistochemical studies have revealed that the volume of the infarction in the middle cerebral artery occlusion model could be decreased by nilvadipine.
Excerpted from Wikipedia’s “nilvadipine” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0